Abstract
Metalloprotein is a basic term for a proteins that contains a metal ion cofactor, have many functions in cells, such as enzymes, transport and storage proteins, and signal transduction proteins. The balance between MMPs and TIMPs are critical in extracellular matrix (ECM) development, morphogenesis, tissue repair and remodeling through MAPK Pathway. Excess of MMPs and TIMPs shows adverse effects, leading to aging diseases such as Alzheimer’s Disease, Cancer, Asthma, Diabetes 2 Mellitus etc. Human Protein Reference Dataset (HPRD) assessed 10 interactions for TIMP1, 5 interactions for TIMP2, 8 interactions for TIMP3 and 2 interactions for TIMP4. The data also assessed 11 interactions for MMP1 and 11 interactions for MMP2. The data from HPRD and Pathwaylinker has also predicted the interaction of Metalloproteins with aging diseases. In the present experimentation, in silico docking models predicted that Iron and Cobalt are activators for TIMPs and MMPs. These metals can serve as an important reactants with good binding affinity for TIMPs and MMPs. Except TIMP1 and TIMP2, all other TIMPs used in present experimentation have good binding affinities with Cyanocobalamin. Hence Cyanocobalamine can be used in treatment of various diseases such as D2M, Cancer, Alzheimer and Parkinson diseases in low dose for longer period, in control of MAPK pathway.
Keywords: MMP, TIMP, Metallic compounds, Protein-protein interactions, Docking, Anti-aging, Bioinformatics, Metalloproteins, ERK1/2, Pulmonary Disease
Letters in Drug Design & Discovery
Title:Protein Interaction Networks in Metallo Proteins and Docking Approaches of Metallic Compounds with TIMP and MMP in Control of MAPK Pathway
Volume: 10 Issue: 1
Author(s): Kaladhar Svgk Dowluru, Potladurthi Chandra Sai, Padmanabhuni Venkata Nageswara Rao, Amajala Krishna chaitanya, Duddukuri Govinda Rao, Vadlapudi Varahala Rao, Potladurthi Suresh, Erva Rajeswara Reddy, Sudabattula Vijaya kumar, Divyakolu Vinod Kumar and Gajjala Bhaskar Reddy
Affiliation:
Keywords: MMP, TIMP, Metallic compounds, Protein-protein interactions, Docking, Anti-aging, Bioinformatics, Metalloproteins, ERK1/2, Pulmonary Disease
Abstract: Metalloprotein is a basic term for a proteins that contains a metal ion cofactor, have many functions in cells, such as enzymes, transport and storage proteins, and signal transduction proteins. The balance between MMPs and TIMPs are critical in extracellular matrix (ECM) development, morphogenesis, tissue repair and remodeling through MAPK Pathway. Excess of MMPs and TIMPs shows adverse effects, leading to aging diseases such as Alzheimer’s Disease, Cancer, Asthma, Diabetes 2 Mellitus etc. Human Protein Reference Dataset (HPRD) assessed 10 interactions for TIMP1, 5 interactions for TIMP2, 8 interactions for TIMP3 and 2 interactions for TIMP4. The data also assessed 11 interactions for MMP1 and 11 interactions for MMP2. The data from HPRD and Pathwaylinker has also predicted the interaction of Metalloproteins with aging diseases. In the present experimentation, in silico docking models predicted that Iron and Cobalt are activators for TIMPs and MMPs. These metals can serve as an important reactants with good binding affinity for TIMPs and MMPs. Except TIMP1 and TIMP2, all other TIMPs used in present experimentation have good binding affinities with Cyanocobalamin. Hence Cyanocobalamine can be used in treatment of various diseases such as D2M, Cancer, Alzheimer and Parkinson diseases in low dose for longer period, in control of MAPK pathway.
Export Options
About this article
Cite this article as:
Svgk Dowluru Kaladhar, Chandra Sai Potladurthi, Venkata Nageswara Rao Padmanabhuni, Krishna chaitanya Amajala, Govinda Rao Duddukuri, Varahala Rao Vadlapudi, Suresh Potladurthi, Rajeswara Reddy Erva, Vijaya kumar Sudabattula, Vinod Kumar Divyakolu and Bhaskar Reddy Gajjala, Protein Interaction Networks in Metallo Proteins and Docking Approaches of Metallic Compounds with TIMP and MMP in Control of MAPK Pathway, Letters in Drug Design & Discovery 2013; 10 (1) . https://dx.doi.org/10.2174/1570180811309010049
DOI https://dx.doi.org/10.2174/1570180811309010049 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Research Toward Potassium Channels on Tumor Progression
Current Topics in Medicinal Chemistry Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development
Current Medicinal Chemistry Functional Non-Synonymous Polymorphisms Prediction Methods: Current Approaches and Future Developments
Current Medicinal Chemistry Patenting of Nanopharmaceuticals in Drug Delivery: No Small Issue
Recent Patents on Drug Delivery & Formulation “Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems
Drug Delivery Letters Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets Floating Drug Delivery Systems for Prolonging Gastric Residence Time: A Review
Current Drug Delivery A Rationale for Inhibiting Progesterone-Related Pathways to Combat Breast Cancer
Current Cancer Drug Targets Potassium Channels in Peripheral Pain Pathways: Expression, Function and Therapeutic Potential
Current Neuropharmacology Synthesis and Biological Evaluation of Scutellaria Flavone Cyclaneaminol Mannich Base Derivatives as Novel CDK1 Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Development of A Novel System Based on Green Magnetic / Graphene Oxide / Chitosan /Allium Sativum / Quercus / Nanocomposite for Targeted Release of Doxorubicin Anti-Cancer Drug
Anti-Cancer Agents in Medicinal Chemistry Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials
Current Medicinal Chemistry Preclinical and Clinical Studies on the Use of Stem Cells for Bone Repair: A Systematic Review
Current Stem Cell Research & Therapy Chemistry in the Bioactivity of Chlorophylls: An Overview
Current Medicinal Chemistry Induction of Tumour Cell Senescence: A New Strategy in Anticancer Treatment
Medicinal Chemistry Reviews - Online (Discontinued) Therapeutic Proteins in Tumors and Targeted Therapeutic Agents for Cancer Patients
Protein & Peptide Letters The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets
Current Medicinal Chemistry Selective Inhibitors of Zinc-Dependent Histone Deacetylases. Therapeutic Targets Relevant to Cancer
Current Pharmaceutical Design Role of NF-κB in the Regulation of Cytochrome P450 Enzymes
Current Drug Metabolism Possibilities of Poly(D,L-lactide-co-glycolide) in the Formulation of Nanomedicines Against Cancer
Current Drug Targets